These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12264128)

  • 1. Lactation pattern in Egyptian women using the Progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Serour G; Hefnawi F
    Contracept Deliv Syst; 1982 Jan; 3(1):53-60. PubMed ID: 12264128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum prolactin levels in lactating women using progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MT
    Popul Sci; 1981; (2):115-20. PubMed ID: 12339477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corpus luteum function in lactating women using the Progestasert system.
    Abdalla MI; Ibrahim II; Osman MI; Badraoui MH; Askalani H
    Contracept Deliv Syst; 1981 Apr; 2(1):127-32. PubMed ID: 12336864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum cortisol level in lactating women using Progestasert system.
    Askalani H; Badraoui MH; Mahrous T; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Popul Sci; 1981; (2):109-14. PubMed ID: 12339476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum-prolactin levels in lactating women using the Progestasert system.
    Badraoui MH; Askalani H; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Contracept Deliv Syst; 1981 Apr; 2(1):121-6. PubMed ID: 12336863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thyroid function in lactating women using the Progestasert system.
    Ibrahim II; Abdalla MI; Badraoui MH; Abdelaal AE
    Contracept Deliv Syst; 1981 Apr; 2(1):139-44. PubMed ID: 12336866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cortisol level in lactating women using the Progestasert system.
    Askalani H; Badraoui MH; Mahrous I; Osman MI; Bayad MA; Ibrahim II; Abdalla MI
    Contracept Deliv Syst; 1981 Apr; 2(1):133-8. PubMed ID: 12336865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine devices containing progesterone.
    Murad F
    Drug Ther (NY); 1977 May; 7(5):119-21. PubMed ID: 12277687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal profile in IUD users.
    Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
    Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting patients and inserting the Progestasert.
    Soderstrom RM
    Am J Gynecol Health; 1989; 3(3-S):17-8. PubMed ID: 12284993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical study comparing the performance of three IUCDs (Multiload Copper 250, Copper T 200, and Lippes Loop C).
    Fakhr MM; Fakhr DM; Hassan AA; Nasser NM
    Popul Sci; 1988; 8():39-53. PubMed ID: 12316112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The risk of pelvic inflammatory disease in women using intra-uterine device--a prospective study at the Kenyatta National Hospital.
    Abdulla SH
    J Obstet Gynaecol East Cent Africa; 1982 Dec; 1(4):156-8. PubMed ID: 12313676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpus luteum function in medicated and non-medicated IUD users.
    Abdalla MI; Ibrahim II; Osman MI; Bayad MA; Hafez ES
    Contracept Deliv Syst; 1983 Jul; 4(3):163-7. PubMed ID: 12265358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of U-coil progesterone releasing device versus inert U-coil IUD.
    Serour GI; Hamza A; El Sheikha Z; Hefnawi FI
    Popul Sci; 1982; (3):121-35. PubMed ID: 12266213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The early post-partum insertion of the nylon ring.
    Ragab MI; Mahran M; Fadel HE
    Ain Shams Med J; 1970 Jan; 21(1):25-7. PubMed ID: 12305245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The end of IUD marketing in the United States: what does it mean for American women?].
    Forrest JD
    Contracept Fertil Sex (Paris); 1987 Mar; 15(3):291-300. PubMed ID: 12341479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Avoidance of the dimensional incompatibility as the main reason for side effects in intrauterine contraception.
    Kurz KH
    Contracept Deliv Syst; 1981 Jan; 2(1):21-9. PubMed ID: 12278585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with Progestasert beyond one year of use.
    Wan LS
    Contracept Deliv Syst; 1981 Jul; 2(3):243-8. PubMed ID: 12278911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.